AML: What to do with your 500-gene mutation report

Earn CME for related activities: www.naccme.com/oln
In this presentation from the 'FLT3 Targets in AML: Evaluating Emerging Clinical Data and Implications on Current Practice’ symposium, Dr. Sanmin Lee breaks down the 500-gene mutation report for patients with acute myeloid leukemia (AML).
© 2018 Imedex, an HMP Company